GE Healthcare Signs Agreement With Healthtrust To Supply Radiopharmaceuticals
Member hospitals will receive extended access to products that support the diagnosis and care of oncological, cardiological and neurological diseases
CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017.
Marco Campione, General Manager of GE Healthcare’s Life Sciences Core Imaging business in the U.S., said: “GE Healthcare offers solutions that help clinicians in all settings of the hospital, including the Radiology and Nuclear Medicine departments, to provide life-saving care every day for the most critical conditions. We are excited to work with HealthTrust through this agreement, expanding availability of these products to a greater number of hospitals around the country to advance diagnostic capabilities and improving patient access. “
GE Healthcare’s core imaging business manufactures pharmaceuticals that are used in the fields of radiology and nuclear medicine to assist physicians in diagnosing a range of diseases, including cancer and cardiovascular and neurological diseases. Through this agreement, HealthTrust member facilities will have access to Life Sciences Core Imaging single-photon emission computed tomography (SPECT) proprietary products, such as Myoview™, Ceretec™, Indium-Oxine™ as well as non-GE Healthcare products, such as MDP, Indium In-111, Thallium chloride and Sodium Iodide 1-123 capsules.
About HealthTrust
HealthTrust (Healthtrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total spend management advisory solutions that leverage our operator experience, scale and innovation. Headquartered in Nashville, Tennessee, HealthTrust (www.healthtrustpg.com) serves approximately 1,600 acute care facilities and members in more than 26,000 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. On Twitter @healthtrustpg.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017.
Marco Campione, General Manager of GE Healthcare’s Life Sciences Core Imaging business in the U.S., said: “GE Healthcare offers solutions that help clinicians in all settings of the hospital, including the Radiology and Nuclear Medicine departments, to provide life-saving care every day for the most critical conditions. We are excited to work with HealthTrust through this agreement, expanding availability of these products to a greater number of hospitals around the country to advance diagnostic capabilities and improving patient access. “
GE Healthcare’s core imaging business manufactures pharmaceuticals that are used in the fields of radiology and nuclear medicine to assist physicians in diagnosing a range of diseases, including cancer and cardiovascular and neurological diseases. Through this agreement, HealthTrust member facilities will have access to Life Sciences Core Imaging single-photon emission computed tomography (SPECT) proprietary products, such as Myoview™, Ceretec™, Indium-Oxine™ as well as non-GE Healthcare products, such as MDP, Indium In-111, Thallium chloride and Sodium Iodide 1-123 capsules.
About HealthTrust
HealthTrust (Healthtrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total spend management advisory solutions that leverage our operator experience, scale and innovation. Headquartered in Nashville, Tennessee, HealthTrust (www.healthtrustpg.com) serves approximately 1,600 acute care facilities and members in more than 26,000 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. On Twitter @healthtrustpg.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.